Related references
Note: Only part of the references are listed.Estimation of DAPT Study Treatment Effects in Contemporary Clinical Practice: Findings From the EXTEND-DAPT Study
Neel M. Butala et al.
CIRCULATION (2022)
Outcomes of prolonged dual anti-platelet therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention: A nationwide registry-based study
Daniel Molager Christensen et al.
AMERICAN HEART JOURNAL (2022)
Challenges of long-term dual antiplatelet therapy use following acute coronary syndromes
Mandeep S. Sidhu et al.
AMERICAN HEART JOURNAL (2022)
Determinants of long-term dual antiplatelet therapy use in post myocardial infarction patients: Insights from the TIGRIS registry
Juan J. Russo et al.
JOURNAL OF CARDIOLOGY (2022)
Evaluation of the Use of Dual Antiplatelet Therapy beyond the First Year after Acute Coronary Syndrome
Clara Bonanad et al.
JOURNAL OF CLINICAL MEDICINE (2022)
Benefits and Risks of Prolonged Duration Dual Antiplatelet Therapy (Clopidogrel and Aspirin) After Percutaneous Coronary Intervention in High-Risk Patients With Diabetes Mellitus
Hao-Yu Wang et al.
AMERICAN JOURNAL OF CARDIOLOGY (2021)
Long-term outcomes of extending dual antiplatelet therapy after drug-eluting stent implantation for acute coronary syndrome: a large single-center study
Jingjing Xu et al.
PLATELETS (2020)
A 4-item PRECISE-DAPT score for dual antiplatelet therapy duration decision-making
Francesco Costa et al.
AMERICAN HEART JOURNAL (2020)
Benefit-Risk Profile of DAPT Continuation Beyond 1 Year after PCI in Patients with High Thrombotic Risk Features as Endorsed by 2018 ESC/EACTS Myocardial Revascularization Guideline
Hao-Yu Wang et al.
CARDIOVASCULAR DRUGS AND THERAPY (2020)
Dual antiplatelet therapy prolongation in high-risk patients with prior myocardial infarction: insights from the post-PCI registry
Marco Ferlini et al.
JOURNAL OF CARDIOVASCULAR MEDICINE (2020)
Long-Term Safety and Efficacy of Extended Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Real-World Practice
Hye-Sung So et al.
CIRCULATION JOURNAL (2020)
Duration of dual antiplatelet therapy and outcome in patients with acute coronary syndrome undergoing percutaneous revascularization: A meta-analysis of 11 randomized trials
Monica Verdoia et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Fourth Universal Definition of Myocardial Infarction (2018)
Kristian Thygesen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Long-Term Outcomes in Patients With Acute Coronary Syndromes Related to Prolonging Dual Antiplatelet Therapy More Than 12 Months After Coronary Stenting
Neil J. Wimmer et al.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2017)
Stopping or continuing clopidogrel 12 months after drug-eluting stent placement: the OPTIDUAL randomized trial
Gerard Helft et al.
EUROPEAN HEART JOURNAL (2016)
Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention
Robert W. Yeh et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials
Said Alsidawi et al.
CARDIOVASCULAR THERAPEUTICS (2015)
Impact of clinical presentation on ischaemic and bleeding outcomes in patients receiving 6-or 24-month duration of dual-antiplatelet therapy after stent implantation: a pre-specified analysis from the PRODIGY(Prolonging Dual-Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) trial
Francesco Costa et al.
EUROPEAN HEART JOURNAL (2015)
Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet Therapy
Dean J. Kereiakes et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2015)
Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction
Robert W. Yeh et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
6-Versus 24-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents in Patients Nonresistant to Aspirin The Randomized, Multicenter ITALIC Trial
Martine Gilard et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
Marc P. Bonaca et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Optimal Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation A Randomized, Controlled Trial
Cheol Whan Lee et al.
CIRCULATION (2014)
Dual-antiplatelet treatment beyond 1 year after drug-eluting stent implantation (ARCTIC-Interruption): a randomised trial
Jean-Philippe Collet et al.
LANCET (2014)
Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents
Laura Mauri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Short- Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary Stenting A Randomized Multicenter Trial
Marco Valgimigli et al.
CIRCULATION (2012)
Standardized Bleeding Definitions for Cardiovascular Clinical Trials A Consensus Report From the Bleeding Academic Research Consortium
Roxana Mehran et al.
CIRCULATION (2011)
Baseline Risk of Major Bleeding in Non-ST-Segment-Elevation Myocardial Infarction The CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) Bleeding Score
Sumeet Subherwal et al.
CIRCULATION (2009)
Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE)
Keith A. A. Fox et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
Share Paper
